45
Participants
Start Date
April 30, 2005
Primary Completion Date
April 30, 2012
Study Completion Date
July 31, 2020
Dendritic Cell Tumor Fusion
"Post-Transplant (Groups A and B): Given under the skin every four weeks for three doses.~Pre-Transplant (Group B): Injected under the skin in upper part of leg or arm prior to stem cell collection for ASCT"
Rambam Medical Center, Haifa
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute/Brigham & Women's Hospital, Boston
Massachusetts General Hospital, Boston
Massachusetts General Hospital
OTHER
Dana-Farber Cancer Institute
OTHER
Brigham and Women's Hospital
OTHER
Rambam Health Care Campus
OTHER
Beth Israel Deaconess Medical Center
OTHER